Standards; Pharmaceutical/API Drug Impurities/Metabolites;
應(yīng)用:
(N-[3-(3-Cyanopyrazolo[1,5-alpha]pyrimidin-5-yl)phenyl]-N-ethylacetamide), can be used for the synthesis of Zaleplon (Z145000), which is a Selective non-benzodiazepine GABAA receptor agonist, and a sedative-hypnotic, almost entirely used for the management/treatment of insomnia.